---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-113772"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T00:30:06.231657+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics closes $5M public offering of stock and warrants

## Summary
- Gross proceeds ~$5.0M; estimated net proceeds ~$4.1M after placement agent fees and expenses.
- Offering of 16,633,400 units at $0.3006/unit; each unit has 1 share (or pre-funded warrant) plus two warrants.
- Series A warrants exercisable at $0.3006/share for 5 years; Series B warrants same price for 18 months.
- Maxim Group LLC and Lake Street Capital Markets served as placement agents; 8% cash fee (4% for affiliates).
- Closing occurred November 2, 2023; proceeds expected for general corporate purposes.

## SEC filing metadata
- accession: 0001104659-23-113772
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923113772/0001104659-23-113772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923113772/tm2329202d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-113772
- JSON: https://secwatch.observer/filing/0001104659-23-113772.json
- Plain text: https://secwatch.observer/filing/0001104659-23-113772.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.